MQS Management LLC Buys Shares of 1,229 Axon Enterprise, Inc. (NASDAQ:AXON)

MQS Management LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 1,229 shares of the biotechnology company’s stock, valued at approximately $362,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. ICA Group Wealth Management LLC bought a new position in Axon Enterprise during the 4th quarter valued at $26,000. Blue Trust Inc. boosted its stake in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares in the last quarter. Trivant Custom Portfolio Group LLC acquired a new position in Axon Enterprise during the first quarter worth about $31,000. First PREMIER Bank bought a new stake in Axon Enterprise in the first quarter worth about $33,000. Finally, Rise Advisors LLC raised its position in Axon Enterprise by 49.0% in the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock worth $45,000 after acquiring an additional 47 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

AXON has been the subject of several research reports. Craig Hallum raised their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Needham & Company LLC restated a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Northland Securities upped their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Barclays increased their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Finally, JMP Securities lifted their target price on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, September 12th. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $365.38.

Insider Buying and Selling at Axon Enterprise

In other news, Director Matthew R. Mcbrady sold 2,000 shares of the company’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The disclosure for this sale can be found here. Insiders sold 317,981 shares of company stock valued at $115,662,734 in the last quarter. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 1.8 %

NASDAQ:AXON opened at $389.74 on Friday. The stock has a market cap of $29.45 billion, a PE ratio of 113.96, a price-to-earnings-growth ratio of 10.34 and a beta of 0.94. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $391.55. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. The stock’s 50-day moving average is $344.06 and its two-hundred day moving average is $316.19.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same period last year, the company posted $0.80 earnings per share. As a group, equities research analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.